Summary
- Current Price
- As of today, DXCM price is $76.65, down -1.71% on
- Current Price All-Time High
- DXCM price is currently -53.51% below its historical high of $164.86 set on
- Market Cap
- DXCM current market cap is $30B, down -10.33% year-over-year
- PE Ratio
- DXCM current PE ratio is 32.78
- Revenue
- DXCM current annual revenue is $4.66B, up +15.60% year-over-year
- Next Earnings
- The next earnings release for DXCM is on
Profile
| Metric | Value |
|---|---|
| Full Name | DexCom, Inc. |
| Ticker | NASDAQ: DXCM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | |
| Website | dexcom.com |
| Employees | 10,200 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $76.65 | |
| Price, 1D Change | -1.71% | |
| Market Cap | $30B | |
| - | ||
| PE Ratio | 32.78 | |
| Beta | 0.71 | |
| Revenue | $5B | |
| Revenue, 1Y Change | +15.60% | |
| EPS | $2.09 | |
| EPS, 1Y Change | +46.73% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 4:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $2.09 | |
| EPS Estimate | N/A | $2.59 |
| EPS Est. Change | N/A | +23.91% |
| Revenue | $4.66B | |
| Revenue Estimate | N/A | $5.22B |
| Revenue Est. Change | N/A | +12.06% |
| Current Price | $76.65 | |
| Price Target | - | $85.00 |
| Price Tgt. Change | - | +10.89% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.69 | $1.42 | -15.54% | |
| $2.07 | $2.09 | +0.83% | |
| $2.59 | N/A | +23.91% | |
| $3.08 | N/A | +47.28% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.02B | $4.03B | +0.25% | |
| $4.66B | $4.66B | +0.15% | |
| $5.22B | N/A | +12.06% | |
| $5.83B | N/A | +24.98% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -8.86% | |
| Price, 3Y | -44.23% | |
| Market Cap, 1Y | -10.33% | |
| Market Cap, 3Y | -44.27% | |
| Revenue, 1Y | +15.60% | |
| Revenue, 3Y | +60.22% | |
| EPS, 1Y | +46.73% | |
| EPS, 3Y | +161.81% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $76.65 | |
| SMA 200 | $67.35 | |
| SMA 50 | $70.48 | |
| EMA 200 | $69.99 | |
| EMA 50 | $71.02 | |
| MACD | $1.46 | |
| Beta | 0.71 | |
| ATR | $2.81 | |
| 14-Day RSI | 59.08 | |
| 10-Day Volatility | 47.11% | |
| 1-Year Volatility | 41.04% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $4.66B | |
| EPS | $2.09 | |
| Gross Profit | $2.80B | |
| Gross Margin | 60.01% | |
| Operating Income | $911.80M | |
| Operating Margin | 19.56% | |
| Net Income | $836.30M | |
| Net Margin | 17.94% | |
| EBITDA | $1.16B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.51 | |
| 1.88 | ||
| 1.59 | ||
| - | ||
| 7 | ||
| 7.04 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 32.78 | |
| 6.14 | ||
| 10.00 | ||
| 22.09 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $2.75B | |
| $2.00B | ||
| $6.34B | ||
| $4.03B | ||
| $3.59B | ||
| $2.14B | ||
| Total Debt | $1.39B | |
| $21.60M | ||
| $344.30M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $3.83B | ||
| $1.89B | ||
| $1.86B | ||
| $1.29B | ||
| $251.80M | ||
| $0.00 | ||
| $252.10M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $1.44B | ||
| $536.00M | ||
| -$1.69B | ||
| Capex | $363.50M | |
| $1.08B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Truist Securities | → | |
| Mizuho | → | |
| Deutsche Bank | → | |
| Piper Sandler | → | |
| TD Cowen | → | |
| Mizuho | → | |
| Stifel | → | |
| Citigroup | → | |
| Canaccord Genuity | → | |
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with DXCM
FAQ
What is the ticker symbol for DexCom, Inc.?
The ticker symbol for DexCom, Inc. is NASDAQ:DXCM
Does DexCom, Inc. pay dividends?
No, DexCom, Inc. does not pay dividends
What sector is DexCom, Inc. in?
DexCom, Inc. is in the Healthcare sector
What industry is DexCom, Inc. in?
DexCom, Inc. is in the Medical Devices industry
What country is DexCom, Inc. based in?
DexCom, Inc. is headquartered in United States
When did DexCom, Inc. go public?
DexCom, Inc. initial public offering (IPO) was on April 14, 2005
Is DexCom, Inc. in the S&P 500?
Yes, DexCom, Inc. is included in the S&P 500 index
Is DexCom, Inc. in the NASDAQ 100?
Yes, DexCom, Inc. is included in the NASDAQ 100 index
Is DexCom, Inc. in the Dow Jones?
No, DexCom, Inc. is not included in the Dow Jones index
When was DexCom, Inc. last earnings report?
DexCom, Inc.'s most recent earnings report was on April 30, 2026
When does DexCom, Inc. report earnings?
The next expected earnings date for DexCom, Inc. is July 30, 2026
Data Sources & References
- DXCM Official Website www.dexcom.com/global
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1093557/000109355726000027/0001093557-26-000027-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- List of NASDAQ 100 Companies www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index
- DXCM Profile on Yahoo Finance finance.yahoo.com/quote/DXCM
- DXCM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dxcm